Kamel Arab
University of Nice Sophia Antipolis
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kamel Arab.
Inflammatory Bowel Diseases | 2008
Stéphane M. Schneider; Rima Al-Jaouni; Jérôme Filippi; Jean‐Baptiste Wiroth; Gilbert Zeanandin; Kamel Arab; Xavier Hébuterne
Background: Patients with Crohns disease (CD) are prone to osteoporosis. A loss of muscle mass, called sarcopenia, is responsible for an increased risk of disability. Many factors associated with osteopenia also decrease muscle mass. The aim of the present study was to measure the prevalence of sarcopenia in CD patients in remission and uncover its relationship with osteopenia. Methods: In all, 82 CD patients (43 female / 39 male; 36 ± 14 years; body mass index [BMI] 21.1 ± 3.4) and 50 healthy volunteers (30F/20M; 39 ± 13 years; BMI 22.2 ± 2.5) were studied. Body composition was assessed using dual‐energy x‐ray absorptiometry. Sarcopenia was defined as an appendicular skeletal muscle index (ASMI) below 5.45 kg/m2 for women and 7.26 for men. Osteopenia was defined as a T‐score for bone mineral density (BMD) (g/cm2) below −1.0. Results: In all, 60% of CD patients were found to be sarcopenic and 30% osteopenic, compared to 16% and 4% of controls, respectively (P < 0.01). ASMI was significantly lower in patients than in controls (6.0 ± 1.1 versus 6.5 ± 1.2; P < 0.05). Sarcopenic patients had significantly (P < 0.01) lower BMI (20.0 ± 3.5 versus 22.7 ± 2.8 kg/m2), lean mass (41.5 ± 9.1 versus 48.1 ± 9.1 kg), and BMD (1.09 ± 0.12 versus 1.15 ± 0.08 g/cm2) than nonsarcopenic patients; 91% of sarcopenic patients were also osteopenic. ASMI correlated with BMD (r = 0.46; P < 0.01) and BMI (r = 0.38; P < 0.01). Conclusions: The prevalence of sarcopenia is high in young CD patients and strongly related to osteopenia. These 2 phenomena may share similar mechanisms. Simultaneous screening for sarcopenia and osteopenia may be useful in CD patients.
Alimentary Pharmacology & Therapeutics | 2010
Geoffroy Vanbiervliet; Sarah Giudicelli-Bornard; Thierry Piche; Frédéric Berthier; Eve Gelsi; Jérôme Filippi; Rodolphe Anty; Kamel Arab; Pierre-Michel Huet; Xavier Hébuterne; A. Tran
Aliment Pharmacol Ther 2010; 32: 225–232
Clinical Nutrition | 2008
Stéphane M. Schneider; Rima Al-Jaouni; Céline Caruba; Jean Giudicelli; Kamel Arab; Florence Suavet; Patricia Ferrari; Isabelle Mothe-Satney; Emmanuel Van Obberghen; Xavier Hébuterne
BACKGROUND & AIMS Anorexia is frequent in the malnourished elderly. We studied the effects of age, nutritional status and refeeding on the expression and secretion of the orexigenic peptide ghrelin. METHODS Four groups were prospectively enrolled: 11 undernourished elderly (80+/-6 y, BMI: 17.4+/-1.9 [Mean+/-SD]), nine well-nourished elderly (76+/-9 y, 23.5+/-2.0), 10 undernourished young (26+/-6 y, 15.1+/-1.9) and 10 well-nourished young (34+/-8 y, 22.2+/-2.7). Fasting and postprandial plasma ghrelin and other hormones (every 30 min) were measured at baseline and after a 21-day enteral nutrition in malnourished patients. Gastric ghrelin mRNA levels were measured by RT-PCR at baseline in all subjects. RESULTS Ghrelin was significantly higher in undernourished (2151+/-871 ng/L) than in well-nourished (943+/-389 ng/L) adults, whereas there were no differences between undernourished (1544+/-758 ng/L) and well-nourished (1154+/-541 ng/L) elderly. Refeeding did not influence ghrelin levels. Gastric ghrelin mRNA levels were similar in all groups. CONCLUSIONS There is an absence of malnutrition-induced increase of plasma ghrelin levels in elderly subjects. This feature, post-transcriptional, may be important in the lack of adaptation of elderly subjects to malnutrition.
Gastroenterologie Clinique Et Biologique | 2004
Eve Gelsi; Frederic Ruitord; Marie-Christine Saint-Paul; Jérôme Filippi; Kamel Arab; Xavier Hébuterne
Resume Nous rapportons le cas d’une malade de 46 ans presentant l’association maladie coeliaque et syndrome de Budd-Chiari pour lequel il n’a pas ete trouve d’etiologie. Cette malade etait originaire d’Afrique du Nord. L’evolution a ete favorable apres un regime sans gluten et une anticoagulation par antivitamine K.
Gastroenterologie Clinique Et Biologique | 2007
Eve Gelsi; Geoffroy Vanbiervliet; Faredj Cherikh; Eugènia Mariné-Barjoan; Régine Truchi; Kamel Arab; Jean-Marie Delmont; Albert Tran
OBJECTIVES A cohort of patient hospitalized for alcohol detoxification between January 2004 and January 2005 were followed prospectively to search for factors predictive factors of sustained abstinence. PATIENTS AND METHODS One hundred and fifteen patients (79 males, 36 females, median age 45.9+/-10.7 years), were hospitalized for alcohol detoxification. Demographic, social, and medical data including daily alcohol intake and co-addictions were noted at inclusion and six months later. Patients who did not attend their six-month visit were contacted by phone. RESULTS Among the 115 included patients, six month follow-up data could be collected for 73. Abstinence rate was 54.8%. Factors predictive of unsuccessful cessation were homelessness (P=0.004), duration of alcohol consumption (P=0.004), smoking (P=0.02), drug substitution (P=0.04) and multiple addictions (P=0.04). At multivariate analysis, multiple addictions was the only independent factor predictive of unsuccessful detoxification. Naltrexone or acamprosate treatments were not associated with a better rate of alcohol detoxification. CONCLUSION Patient follow-up is problematic due to the large number of dropouts among alcoholics. Early screening in search for factors predictive of unsuccessful detoxification (long duration of alcohol consumption, multiple addiction) would be helpful in elaborating appropriate pluridisciplinary management.
Clinical Nutrition | 2006
Stéphane M. Schneider; Fernand Girard-Pipau; Rodolphe Anty; Esmeralda G.M. van der Linde; Bertine J. Philipsen-Geerling; J. Knol; Jérôme Filippi; Kamel Arab; Xavier Hébuterne
Gastroenterologie Clinique Et Biologique | 2002
Geoffroy Vanbiervliet; Rodolphe Anty; Stéphane M. Schneider; Kamel Arab; Patrick Rampal; Xavier Hébuterne
Gastroenterologie Clinique Et Biologique | 2005
Jérôme Filippi; Pierre Mambrini; Kamel Arab; Stéphane M. Schneider; Xavier Hébuterne
Gastroenterologie Clinique Et Biologique | 2009
Gilbert Zeanandin; F. Berthier; S. Gonfrier; Kamel Arab; Xavier Hébuterne; Stéphane M. Schneider
/data/revues/03998320/003106-7/595/ | 2008
Eve Gelsi; Geoffroy Vanbiervliet; Faredj Cherikh; Eugènia Mariné-Barjoan; Régine Truchi; Kamel Arab; Jean-Marie Delmont; A. Tran